Bulletin de la Dialyse à Domicile最新文献_第3页

Equipement et traitement d’eau pour la gestion quotidienne de l’hémodialyse à domicile 家庭血液透析日常管理的设备和水处理

Bulletin de la Dialyse à Domicile Pub Date : 2022-09-06 DOI: 10.25796/bdd.v5i3.67793

T. Serrato

引用次数: 0

Cost of Home Dialysis in France 法国家庭透析的费用

Bulletin de la Dialyse à Domicile Pub Date : 2022-09-06 DOI: 10.25796/bdd.v5i3.67593

G. Rostoker

{"title":"Cost of Home Dialysis in France","authors":"G. Rostoker","doi":"10.25796/bdd.v5i3.67593","DOIUrl":"https://doi.org/10.25796/bdd.v5i3.67593","url":null,"abstract":"Summary \u0000Medico-economic evaluation is defined as economic evaluation applied to the health field. It is a comparative analysis of different diagnostic, therapeutic or preventive strategies, based on their costs and health outcomes. We have only one medico-economic study on the costs of dialysis in France, carried out by the Haute Autorité de Santé, which covered the year 2012 and consisted of cross-referencing 3 databases: the Registre Réseau Épidémiologique et Information en Néphrologie and the Système National d’Informations Inter-régimes de l’Assurance Maladie et de l’Hospitalisation. Analyses focused on prevalent patients, incident patients and key patient characteristics: age, presence of diabetes and care trajectories. The average monthly cost varied considerably according to the management modality, from 3774 euros/month in autonomous continuous ambulatory peritoneal dialysis (CAPD) to 7253 euros/month in center-based hemodialysis. The monthly cost of therapies according to the patient profile appears to be strongly affected by the diabetic status of the patients. This analysis shows the high cost of transport for patients on in-center hemodialysis (20% of total expenditures), and even higher for nursing care in assisted CAPD (37% of total expenditures). The total tariff decreases from 2014 to 2020 were -17.6% for center-based hemodialysis and -9.8% for the low medicalized dialysis unit (LMDU), while the total 2014–2021 tariff increases were +9.3% for CAPD and +9.1% for automated peritoneal dialysis (APD). Paradoxically, these price changes have increased the cost of assisted peritoneal dialysis, which is now almost at the same level of overall cost as in-center hemodialysis for the French health insurance system. The ongoing study of the Physidia Laboratory’s retrospective cohort on daily home hemodialysis (DHH) should allow us to know the current cost of each hemodialysis technique currently practiced in France, including DHH.","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"71 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127161493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Simplified calculation of month-on-month annualized peritoneal dialysis associated peritonitis rate – Validation in ANZDATA, NZ PD and RDPLF registries 简化计算每月腹膜透析相关腹膜炎的年化率- ANZDATA, NZ PD和RDPLF注册验证

Bulletin de la Dialyse à Domicile Pub Date : 2022-09-06 DOI: 10.25796/bdd.v5i3.67753

M. Marshall, Gerald P Waters, C. Verger

{"title":"Simplified calculation of month-on-month annualized peritoneal dialysis associated peritonitis rate – Validation in ANZDATA, NZ PD and RDPLF registries","authors":"M. Marshall, Gerald P Waters, C. Verger","doi":"10.25796/bdd.v5i3.67753","DOIUrl":"https://doi.org/10.25796/bdd.v5i3.67753","url":null,"abstract":"Peritonitis is the most important therapy-related complication of peritoneal dialysis (PD). Monthly or quarterly PD peritonitis rate statistics are used to identify special cause variation within or between individual PD centres, to highlight any need for quality improvement. Unfortunately, many PD centres do not accurately “patient flow” (i.e., when patients start and finish on PD), and therefore cannot measure PD peritonitis rate. In this study, we validate an estimating formula for month-on-month annualised PD peritonitis rate, that calculates time-at-risk from “patient stock” (i.e., the number of prevalent patients on PD at the beginning and end of the month). We compared centers’ estimated peritonitis rates with gold-standard measurements in the Australia and New Zealand Dialysis and Transplant Registry / New Zealand PD Registry, and Le Registre de Dialyse Péritonéale de Langue Française et hémodialyse à domicile. A total of 268 centers from 9 countries with 1,020,260 patient-months of follow-up and 19,669 episodes of peritonitis were modeled. Overall agreement was excellent between estimates and gold-standard measurements with a concordance correlation coefficient (CCC) of 0.998 (95% confidence interval [CI] 0.998-0.998) in both registries. There was statistically significant lower agreement for smaller centers, although the CCC was still greater than 0.995. There were no instances of clinically significant misclassification of centers as being compliant or non-compliant with PD peritonitis standards with the use of the estimating formula. The simplified method of calculating the PD peritonitis rate is accurate and will allow more centers around the world to measure, report, and work on reducing PD peritonitis rates.","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128706353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Stage V Chronic Kidney Disease: A plea for Home Dialysis 第五期慢性肾脏疾病:家庭透析的请求

Bulletin de la Dialyse à Domicile Pub Date : 2022-09-06 DOI: 10.25796/bdd.v5i3.67633

B. Issad, G. Rostoker

{"title":"Stage V Chronic Kidney Disease: A plea for Home Dialysis","authors":"B. Issad, G. Rostoker","doi":"10.25796/bdd.v5i3.67633","DOIUrl":"https://doi.org/10.25796/bdd.v5i3.67633","url":null,"abstract":"Summary \u0000Overall, home dialysis remains underutilized in much of the world. It is only in some parts of the world, such as Hong Kong, Mexico, Thailand, the Netherlands, Finland, Denmark, Iceland, Australia, Canada and New Zealand, that home dialysis is used for more than 20% of the dialysis population. It is observed that in most high- and middle-income countries, home dialysis is generally more economical than center-based dialysis. \u0000According to the results of the REIN 2020 registry, the share of out-of-center dialysis in France has been increasing since 2012. This is mainly due to the increase in the number of patients treated in low medicalized dialysis units (LMDUs) (+7.3% per year between 2012 and 2016, then +3.8% between 2016 and 2020). In contrast, the proportion of patients treated at home has changed little. The percentage of patients on peritoneal dialysis is decreasing (-1.8% per year). Home hemodiaysis is increasing (+10.3% per year) but remains very marginal (1% of dialysis patients). Finally, the advanced age of dialysis patients, which is constantly increasing, cannot be ignored. The proportion of these very old patients has increased from 10.5% in 2012 to 12.5% in 2020. However, during the COVID-19 epidemic, several articles in the literature have demonstrated the protective effect of home dialysis in all its forms (peritoneal dialysis and home hemodialysis) against SARS-CoV-2 infection. \u0000We report on the status of home dialysis in France, its advantages and proposals for its development, as presented at the Home Dialysis Day (DIADOM) of University Seminars of Nephrology (SUN) in Paris in January 2022.","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114251934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Overview of ISPD 2022 guideline recommendations for peritonitis prevention and treatment. ISPD 2022预防和治疗腹膜炎指南建议概述

Bulletin de la Dialyse à Domicile Pub Date : 2022-06-15 DOI: 10.25796/bdd.v5i2.66753

M. Taghavi, M. Dratwa

引用次数: 2

A testimony about home dialysis in Tougué (Guinea) using the NxStage® portable haemodialysis system 关于在几内亚tougu<s:1>使用NxStage®便携式血液透析系统进行家庭透析的证词

Bulletin de la Dialyse à Domicile Pub Date : 2022-06-15 DOI: 10.25796/bdd.v5i2.66703

Alhassane Diallo

{"title":"A testimony about home dialysis in Tougué (Guinea) using the NxStage® portable haemodialysis system","authors":"Alhassane Diallo","doi":"10.25796/bdd.v5i2.66703","DOIUrl":"https://doi.org/10.25796/bdd.v5i2.66703","url":null,"abstract":"Several testimonials have already appeared in the Bulletin de la Dialyse à Domicile or the website of the French-language Peritoneal Dialysis Registry detailing patient experiences remarkable for their empowerment at home (1), or for the achievement of sports and human challenges such as that of Fabrice HURE (2) or Jean Louis CLEMENDOT (3). The testimony we report is the travel story of Mr Alhassane DIALLO, a dialysis patient who wanted to join his family in Guinea at a great distance from any dialysis clinic, a journey that home dialysis allowed, but not without hardships. We hope that this experience can help other patients with independent travel plans. The success of this project was due to the unwavering determination of Mr DIALLO but also to a collective organization that requested the administrative, logistical and pharmacy services of the AUB Santé Foundation and close cooperation between the French and Guinean medical teams. This experience shows us how important travel limitations are in the experience of dialysis patients, and particularly in that of expatriate patients. In addition, it highlights the significant inequalities in access to care in the world: Guinea has only one dialysis centre, in Conakry. \u0000Eric LARUELLE, MD, Nephrologist, AUB Santé Foundation* \u0000Picault, Christelle. 2019. « Dialyse Longue Nocturne à Domicile à Bas débit De Dialysat. ». Bulletin De La Dialyse à Domicile 2 (1), 33-36. https://doi.org/10.25796/bdd.v2i1.19143. \u00002/ Fabrice Huré. La montagne dans le sang. Un témoignage humain d’un patient dialysé de nuit pour les autres patients. Bulletin Dialyse Domicile N°1.Vol 2. Avril 2019 DOI : https://doi.org/10.25796/bdd.v2i1.19153 \u00003/ Témoignages : la traversée de l'Atlantique en solitaire en dialyse péritonéale.https://www.rdplf.org/information-patients/temoignages-patients.html?id=337","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126634161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Traduction française de «Recommandations de l’ ISPD sur la péritonite : Mise à jour 2022 de la prévention et du traitement. » 《ISPD关于腹膜炎的建议:2022年预防和治疗更新》的英文翻译。»

Bulletin de la Dialyse à Domicile Pub Date : 2022-06-15 DOI: 10.25796/bdd.v5i2.66003

M. Dratwa, C. Verger

{"title":"Traduction française de «Recommandations de l’ ISPD sur la péritonite : Mise à jour 2022 de la prévention et du traitement. »","authors":"M. Dratwa, C. Verger","doi":"10.25796/bdd.v5i2.66003","DOIUrl":"https://doi.org/10.25796/bdd.v5i2.66003","url":null,"abstract":"Informations concernant cette traduction \u0000Dans le cadre d’un accord de partenariat entre l’ISPD et le RDPLF, le RDPLF est le traducteur français officiel des recommandations de l’ISPD (https://doi.org/10.25796/bdd.v4i3.63033). La traduction ne donne lieu à aucune compensation financière de la part de chaque société et le RDPLF s’engage à traduire fidèlement le texte original sous la responsabilité de deux néphrologues connus pour leur expertise dans le domaine. Avant publication le texte a été soumis à l’accord de l’ISPD. La traduction est disponible sur le site de l’ISPD et dans le Bulletin de la Dialyse à Domicile. \u0000Cette traduction est, comme l’original, libremement téléchargeable sous licence copyright CC By 4.0 https://creativecommons.org/licenses/by-nc/4.0/ \u0000Cette traduction est destinée à aider les professionnels de la communauté francophone à prendre connaissance des recommandations de l’ISPD dans leur langue maternelle. \u0000Toute référence dans un article doit se faire au texte original en accès libre : Peritoneal Dialysis International https://journals.sagepub.com/doi/10.1177/08968608221080586 Dans les articles rédigés pour des revues françaises, conserver la référence à la version originale anglaise ci dessus, mais ajouter «version française https://doi.org/10.25796/bdd.v5i2.66003 \u0000Traducteurs Dr Christian Verger, néphrologue, président du RDPLFRDPLF, 30 rue Sere Depoin, 95300 Pontoise – France \u0000Professeur Max Dratwa, néphrologueCHU Brugmann – Bruxelles – Belgique","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"104 12","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120968064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Peritoneal infection with Geotrichum spp in peritoneal dialysis in Dakar: a case report with literature review. 达喀尔地区腹膜透析患者腹膜感染土曲菌1例并文献复习。

Bulletin de la Dialyse à Domicile Pub Date : 2022-05-02 DOI: 10.25796/bdd.v5i2.65493

B. Ba, M. Faye, M. Faye, E. Ka

引用次数: 0

Traduction française de «L’activité physique et l’exercice en dialyse péritonéale : recommandations pratiques de la Société Internationale pour la Dialyse Péritonéale (ISPD)et le réseau Peritoneal Dialysis and the Global Renal Exercise.» 腹膜透析中的身体活动和锻炼:国际腹膜透析协会(ISPD)和腹膜透析网络和全球肾脏锻炼的实用建议。

Bulletin de la Dialyse à Domicile Pub Date : 2022-04-06 DOI: 10.25796/bdd.v5i1.65163

C. Verger, M. Dratwa

引用次数: 0

Outcomes of patients with Cholesterol crystal embolism treated by peritoneal dialysis: retrospective study from the RDPLF registry. 经腹膜透析治疗胆固醇结晶栓塞患者的结局:来自RDPLF登记的回顾性研究。

Bulletin de la Dialyse à Domicile Pub Date : 2022-04-06 DOI: 10.25796/bdd.v5i1.65303

A. Testa, E. Chamorey, F. Lavainne, C. Verger

{"title":"Outcomes of patients with Cholesterol crystal embolism treated by peritoneal dialysis: retrospective study from the RDPLF registry.","authors":"A. Testa, E. Chamorey, F. Lavainne, C. Verger","doi":"10.25796/bdd.v5i1.65303","DOIUrl":"https://doi.org/10.25796/bdd.v5i1.65303","url":null,"abstract":"Cholesterol crystal embolisms disease (CED) is a systemic disease characterized by tissue ischemia and microinflammation related to occlusion of arterioles by microemboli from ulcerated atheromatous plaques. The kidney is one of the most affected organs, often requiring dialysis. Our study examines the outcomes of a cohort of patients with CED treated with peritoneal dialysis (PD). As anticoagulants can favor emboli, peritoneal dialysis may theoretically have an advantage. \u0000From the database of the French Language Peritoneal Dialysis Registry (RDPLF), between January 1, 1995, and December 31, 2021, we selected patients treated with PD for >90 days and with an age >18 years. On the basis of the variables of patient autonomy, diabetes, BMI, modified Charlson index, age, sex, pre-PD treatment, causes of death, causes of transfer to hemodialysis, and peritonitis, three types of survival were estimated (patient, technical, and composite). After adjustment by propensity scores and taking into account competitive risks, 2 groups of patients were constituted on the basis of baseline nephropathy: emboli group vs. control group. \u0000Patient survival and strict technical survival are not associated with the type of nephropathy (CED versus others). Composite technical survival (uncensored for deaths and transfers to hemodialysis) was only associated with cholesterol emboli nephropathy in the multivariate analysis adjusted for diabetes, autonomy, and age of the patient at the start of the dialysis treatment (p=0.011; 95% CI [0.736 [0.581-0.931]]). \u0000Our study from the RDPLF database shows no difference in technical and patient survival in a cohort of patients with CED vs. a control group. It also confirms that PD may represent an adequate choice in this pathology.","PeriodicalId":366938,"journal":{"name":"Bulletin de la Dialyse à Domicile","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121528805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0